Who Paid My Doc
CS003 US Early Feasibility Study
Research payments
$67,809
Through program year 2025, $67,809 in research payments was reported against CS003 US Early Feasibility Study, across 26 payments, paid by Galvanize Therapeutics, Inc.
- Paid by
- Galvanize Therapeutics, Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $19,032 | 7 |
| 2024 | Research | $12,746 | 9 |
| 2023 | Research | $31,566 | 7 |
| 2022 | Research | $4,465 | 3 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
5 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.